CEimpact Podcast

The DCP Study: HCTZ vs Chlorthalidone

January 30, 2023 CEimpact Season 4 Episode 5
CEimpact Podcast
The DCP Study: HCTZ vs Chlorthalidone
Show Notes

Hydrochlorothiazide is the go-to thiazide for hypertension control despite better data for chlorthalidone. Join host Geoff Wall as he evaluates the new randomized controlled study to determine what is the best thiazide.

The GameChanger
Several pharmacologic differences exist between hydrochlorothiazide and chlorthalidone. The new DCP Study did not find any differences in cardiovascular outcomes.

Show Segments
00:00 - Introductions
02:20 - History of HCTZ vs Chlorthalidone
05:26 - The Diuretic Comparison Project: HCTZ vs Chlorthalidone
12:27 - The GameChanger: DCP Results
19:48 - Connecting to Practice: Choosing Between the Two
21:47 - Closing Remarks

Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.

Redeem your CPE or CME here

CPE (Pharmacist)
CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership
Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the pharmacologic differences of hydrochlorothiazide and chlorthalidone
2. Apply the results of the DCP Study to clinical practice

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-025-H01-P
Initial release date: 01/30/2023
Expiration date: 01/30/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:

Download the CEimpact App for Free Continuing Education + so much more!